For instance, GW4869, an inhibitor of exosome release, was found to attenuate CD44 expression and reverse EMT in PMCs by inhibiting exosome release in ovarian cancer cells, thereby inhibiting ovarian cancer invasion 13. Here, CD44 is linked to ovarian carcinoma.